A method for preventing and/or treating diabetic nephropathies by means of plasminogen. Compared to other existing drugs for treating diabetic nephropathies, plasminogen has significant effects in improving a microvascular injury of kidney, reducing the thickening of the glomerular basement membrane and the glomerular mesangium, and the like.